Showcases Stock ranks Forex

Infinity Pharmaceuti (INFI)
0.8093  0.01 (1.19%) 08-08 16:00
Open: 0.7758 Pre. Close: 0.7998
High: 0.829 Low: 0.7758
Volume: 448,296 Market Cap: 72M
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company. Infinity Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Cambridge, Massachusetts.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 0.83 - 0.833 0.833 - 0.836
Low: 0.773 - 0.776 0.776 - 0.779
Close: 0.805 - 0.809 0.809 - 0.814
Stock Technical Analysis
Target: Six months: 0.97
One year: 1.13
Support: Support1: 0.68
Support2: 0.59
Resistance: Resistance1: 0.83
Resistance2: 0.97
Pivot: 0.72
Moving Averages: MA(5): 0.74
MA(20): 0.70
MA(100): 0.77
MA(250): 1.66
MACD: MACD(12,26): 0.02
%K %D: %K(14,3): 87.26
%D(3): 70.33
RSI: RSI(14): 64.73
52-Week: High: 3.89
Low: 0.46
Change(%): -74.1
Average Vol(K): 3-Month: 650
10-Days: 298
Price, MAs and Bollinger Bands
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.

[ INFI ] has closed below upper band by 8.2%. Bollinger Bands are 20.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Tue, 02 Aug 2022
Infinity Pharmaceuticals Annou -

Tue, 02 Aug 2022
North American Morning Briefing: Stock Futures -2- - Morningstar

Mon, 01 Aug 2022
The Global Hedgehog Pathway Inhibitors Market is expected to grow by $ 385.52 mn during 2022-2026, accelerating at a CAGR of 13% during the forecast period - Yahoo Finance

Thu, 14 Jul 2022
Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Sees Large Drop in Short Interest - Defense World

Tue, 17 May 2022
Infinity Pharmaceuticals to Participate in Upcoming H.C. Wainwright Global Investment Conference - Business Wire

Tue, 03 May 2022
Infinity Pharmaceuticals, Inc. (INFI) CEO Adelene Perkins on Q1 2022 Results - Earnings Call Transcript - Seeking Alpha

Financial Analysis
Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  NASDAQ Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M)
Shares Float (M) 89.16
% Held by Insiders 75790000.00
% Held by Institutions 1.25
Shares Short (K) 4450
Shares Short Prior Month (K)
Stock Financials
EPS -45430000.000
Book Value (p.s.)
Profit Margin
Operating Margin -2.00
Return on Assets (ttm) 247.1
Return on Equity (ttm) -31.0
Qtrly Rev. Growth 2040000.0
Gross Profit (p.s.) 19.800
Sales Per Share -74.270
EBITDA (p.s.) -15455000.000
Qtrly Earnings Growth -0.52
Operating Cash Flow (M)
Levered Free Cash Flow (M) -40.68
Stock Valuation
PE Ratio
PEG Ratio -0.01
Price to Book value
Price to Sales -0.01
Price to Cash Flow 14.71
Stock Dividends
Dividend Yield
Dividend Growth 1380000.000

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android